PE20130390A1 - Composiciones vacunales a base de sticholisina encapsulada en liposomas - Google Patents
Composiciones vacunales a base de sticholisina encapsulada en liposomasInfo
- Publication number
- PE20130390A1 PE20130390A1 PE2013000004A PE2013000004A PE20130390A1 PE 20130390 A1 PE20130390 A1 PE 20130390A1 PE 2013000004 A PE2013000004 A PE 2013000004A PE 2013000004 A PE2013000004 A PE 2013000004A PE 20130390 A1 PE20130390 A1 PE 20130390A1
- Authority
- PE
- Peru
- Prior art keywords
- liposomes
- sticholysin
- encapsulated
- compositions based
- anemone
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000002502 liposome Substances 0.000 title abstract 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 150000002632 lipids Chemical class 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 241001083548 Anemone Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000024932 T cell mediated immunity Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 238000005538 encapsulation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 201000008827 tuberculosis Diseases 0.000 abstract 1
- 239000003981 vehicle Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
SE REFIERE A UNA COMPOSICION DE VACUNA QUE CONTIENE UN VEHICULO PARA VACUNA QUE INDUCE UNA RESPUESTA INMUNE CELULAR Y COMPRENDE LA ENCAPSULACION EN VESICULAS LIPIDICAS DE PROTEINAS OBTENIDAS DE LA ANEMONA STICHODACTYLA HELIANTHUS TAL COMO StIW111C, StIW111Cirrev O StII INACTIVADA POR TRATAMIENTO TERMICO JUNTO CON UN ANTIGENO QUE ES UNA PROTEINA O POLIPEPTIDO ASOCIADO AL CANCER, SIDA O TUBERCULOSIS; EN DONDE LOS LIPOSOMAS SON OBTENIDOS POR EL PROCEDIMIENTO DE DESHIDRATACION-REHIDRATACION CUYA COMPOSICION LIPIDICA ES DIPALMITOILFOSFATIDILCOLINA:COLESTEROL EN UNA RELACION MOLAR 1:1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20100144A CU20100144A7 (es) | 2010-07-06 | 2010-07-06 | Composiciones vacunales a base de sticholisina encapsulada en liposomas |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20130390A1 true PE20130390A1 (es) | 2013-04-11 |
Family
ID=44533576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2013000004A PE20130390A1 (es) | 2010-07-06 | 2011-07-05 | Composiciones vacunales a base de sticholisina encapsulada en liposomas |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US8697093B2 (es) |
| EP (1) | EP2591802B1 (es) |
| JP (1) | JP5685646B2 (es) |
| KR (1) | KR101455055B1 (es) |
| CN (1) | CN102971011B (es) |
| AR (1) | AR081661A1 (es) |
| AU (1) | AU2011276812B2 (es) |
| BR (1) | BR112012033284B1 (es) |
| CA (1) | CA2802443C (es) |
| CL (1) | CL2012003674A1 (es) |
| CO (1) | CO6640312A2 (es) |
| CU (1) | CU20100144A7 (es) |
| EA (1) | EA025333B1 (es) |
| ES (1) | ES2576851T3 (es) |
| MX (1) | MX2012015173A (es) |
| MY (1) | MY167896A (es) |
| PE (1) | PE20130390A1 (es) |
| PH (1) | PH12013500036A1 (es) |
| SG (1) | SG186931A1 (es) |
| TN (1) | TN2012000592A1 (es) |
| TW (1) | TWI457145B (es) |
| UA (1) | UA111944C2 (es) |
| WO (1) | WO2012003814A1 (es) |
| ZA (1) | ZA201300059B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6238366B2 (ja) * | 2012-08-28 | 2017-11-29 | 国立大学法人北海道大学 | 非極性溶媒に分散性を有する細菌菌体成分を内封する脂質膜構造体およびその製造方法 |
| KR102069670B1 (ko) * | 2017-03-02 | 2020-01-23 | 단디바이오사이언스 주식회사 | 면역활성물질을 포함하는 다중도메인캡슐, 이의 제조방법, 및 이를 포함하는 면역조절 조성물 |
| US20200230057A1 (en) * | 2017-07-10 | 2020-07-23 | Immunovaccine Technologies Inc. | Pharmaceutical Compositions, Methods for Preparation using Lipid Vesicle Particles of Defined Size, and Uses Thereof |
| CN113041346A (zh) * | 2019-12-26 | 2021-06-29 | 复旦大学 | 一种细菌毒素疫苗及其在预防细菌感染中的用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE182791T1 (de) | 1991-05-08 | 1999-08-15 | Schweiz Serum & Impfinst | Wiederhergestellte influenza-virosomen mit immunostimulierenden und immunoverstärkenden eigenschaften und diese enthaltende impfstoffe |
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| EP1797895A1 (en) | 2005-12-16 | 2007-06-20 | Pevion Biotech Ltd. | An adjuvant system comprising virosomes and liposomes |
| KR101332538B1 (ko) | 2006-12-04 | 2013-11-22 | 도꾸리쯔 교세이호징 노우교 · 쇼쿠힝 산교 기쥬쯔 소고 겡뀨 기꼬우 | 바이오미네랄 함유물의 제조방법 및 유기 양액재배법 |
-
2010
- 2010-07-06 CU CU20100144A patent/CU20100144A7/es unknown
-
2011
- 2011-05-07 UA UAA201301383A patent/UA111944C2/uk unknown
- 2011-06-24 AR ARP110102211A patent/AR081661A1/es not_active Application Discontinuation
- 2011-06-29 TW TW100122821A patent/TWI457145B/zh not_active IP Right Cessation
- 2011-07-05 KR KR1020137000208A patent/KR101455055B1/ko not_active Expired - Fee Related
- 2011-07-05 CN CN201180033067.XA patent/CN102971011B/zh not_active Expired - Fee Related
- 2011-07-05 JP JP2013517001A patent/JP5685646B2/ja not_active Expired - Fee Related
- 2011-07-05 AU AU2011276812A patent/AU2011276812B2/en not_active Ceased
- 2011-07-05 CA CA2802443A patent/CA2802443C/en active Active
- 2011-07-05 US US13/808,276 patent/US8697093B2/en active Active
- 2011-07-05 PH PH1/2013/500036A patent/PH12013500036A1/en unknown
- 2011-07-05 EA EA201291449A patent/EA025333B1/ru not_active IP Right Cessation
- 2011-07-05 EP EP11743950.5A patent/EP2591802B1/en active Active
- 2011-07-05 ES ES11743950.5T patent/ES2576851T3/es active Active
- 2011-07-05 WO PCT/CU2011/000004 patent/WO2012003814A1/es not_active Ceased
- 2011-07-05 BR BR112012033284-8A patent/BR112012033284B1/pt not_active IP Right Cessation
- 2011-07-05 PE PE2013000004A patent/PE20130390A1/es not_active Application Discontinuation
- 2011-07-05 SG SG2013000690A patent/SG186931A1/en unknown
- 2011-07-05 MX MX2012015173A patent/MX2012015173A/es active IP Right Grant
- 2011-07-05 MY MYPI2013000019A patent/MY167896A/en unknown
-
2012
- 2012-12-13 TN TNP2012000592A patent/TN2012000592A1/en unknown
- 2012-12-18 CO CO12229159A patent/CO6640312A2/es unknown
- 2012-12-21 CL CL2012003674A patent/CL2012003674A1/es unknown
-
2013
- 2013-01-03 ZA ZA2013/00059A patent/ZA201300059B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20161242A1 (es) | Formulaciones de lipidos para la administracion de arn mensajero | |
| PH12019501824A1 (en) | Anti-gprc5d antibody and molecule comprising the antibody | |
| MY169837A (en) | Immunogenic compositions of staphylococcus aureus antigens | |
| ECSP13012436A (es) | ANTICUERPOS PEPTÍDICOS BETA AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS | |
| AR083561A1 (es) | Preparacion de una construccion antigenica | |
| UY31942A (es) | Formulaciones de adyuvante comprendiendo combinaciones de triterpenoides, esteroles, inmunomoduladores, polímeros y estimuladores de th2, procedimientos de preparación, composiciones y aplicaciones. | |
| EA201391240A1 (ru) | Слитые белки и комбинированные вакцины, содержащие белок е и пилин а haemophilus influenza | |
| CR20170419A (es) | Nuevos péptidos y nueva combinación de péptidos para el uso en la inmunoterapia contra el cáncer de páncreas y otros tipos de cáncer. | |
| CR20180027A (es) | Nuevos péptidos y nuevas combinaciones de péptidos para el uso en la misma terapia contra el cáncer epitelial de ovario y otros tipos de cáncer. | |
| MX2012004868A (es) | Proteinas de enlace al antigeno il-23 humanas. | |
| MX382826B (es) | Anticuerpos dkk1 y metodos de uso. | |
| MX392812B (es) | Lipidos cationicos de trialquilo y metodos de uso de los mismos. | |
| AR060163A1 (es) | Micelas de proteina de suero | |
| JOP20200039A1 (ar) | مُستحضر صيدلي يشتمل على hcg مأشوب | |
| PE20130390A1 (es) | Composiciones vacunales a base de sticholisina encapsulada en liposomas | |
| BR122018075729B8 (pt) | flavivírus na preparação de uma composição de vacina | |
| ECSP13012536A (es) | Composiciones de anticuerpo y métodos de uso | |
| CR10555A (es) | Vacunas para malaria | |
| UA110024C2 (uk) | Вакцинний вектор і спосіб посилення імунної відповіді | |
| AR100768A1 (es) | Método para disminuir la inmunogenicidad de proteínas y péptidos | |
| CR8999A (es) | Composicion para beber para el cuidado de la piel | |
| EP2762153A3 (en) | Vaccine composition for mucosal administration | |
| UY29248A1 (es) | Indoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización | |
| UY29036A1 (es) | Derivados de oxopiperidina, su preparacion y su aplicacion en terapeutica | |
| IN2013DE03735A (es) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |